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The present study seeks to determine potential associations between viral infections
and neuropsychiatric diseases. To address this issue, we investigated the peptide
commonalities between viruses that have been related to psychiatric and neurological
disorders—such as rubella, human immunodeficiency virus, and herpesviruses—and
human distal-less homeobox (DLX) proteins expressed in developing brain—namely,
DLX1, DLX2, DLX5, and DLX6. Peptide matching analyses revealed a high degree
of pentapeptide sharing. From an immunological perspective, this overlap is relevant
because pentapeptides are endowed with immunogenicity and antigenicity—that is, they
are immune determinants. Moreover, infection-induced immune cross-reactions might
have functional, spatial, and temporal implications related to the functions and expression
patterns of DLX1 and DLX5 in the fetal and adult human brain. In sum, our data support
the hypothesis that viral infections may be linked to neuropsychiatric diseases through
autoimmune cross-reactions caused by molecular mimicry between viral proteins and
brain-specific DLX self-antigens.
Keywords: viral infections, neuropsychiatric diseases, language disorders, fetal and adult neurogenesis, DLX
proteins, peptide sharing, cross-reactivity, autoimmunity
INTRODUCTION
Infections, neuropsychiatric diseases, and language disorders are often concomitant pathological
events that can have early etiological roots in fetal life and then become apparent in any stage
across the life span of the individual, from the postnatal period to the late age (Yolken and
Torrey, 1995; Coplan et al., 1998; Arias et al., 2012; Brown, 2012, 2015; Khandaker et al., 2013).
However, it is unclear how these pathological events are mechanistically interlinked and temporally
related, most likely because the wide spectrum of infectious agents and the varying extent of
the numerous neuropsychiatric symptoms make it difficult to dissect the molecular correlations
between infections and brain damage (Ludlow et al., 2016).
During the past few decades, scientific-clinical research examined the assumption that infections
may relate to neuropsychiatric disturbances through autoimmune mechanisms (Knuesel et al.,
2014; Severance et al., 2014; Blomström et al., 2015; Estes and McAllister, 2016; de Haan et al.,
2017). More recently, it was suggested that anti-pathogen immune responses cross-reacting
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with the human NMDA receptor 2A subunit—alterations of
which are involved in language dysfunctions (Carvill et al., 2013;
Turner et al., 2015)—might represent a pathologic background
for infections and many neurodegenerative disorders, ranging
from schizophrenia to frontotemporal dementia (Lucchese,
2016).
The current study is extended to four members of the DLX
transcription factor (TF) family—namely DLX1, DLX2, DLX5,
and DLX6—that have been thoroughly investigated in numerous
studies on neurodevelopment. Indeed, the four TFs are expressed
during early fetal neurodevelopment (Merlo et al., 2000;
Panganiban and Rubenstein, 2002) and are associated with the
specification of γ-aminobutyric acid (GABA)ergic interneurons
in the vertebrate forebrain subventricular zone (SVZ) as well as
with granule neurons in the subgranular zone (SGZ) (Simeone
et al., 1994; Anderson et al., 1997a,b). The issue appears to
be important especially when considering that cognitive and
emotional tasks occur in the neurogenic areas (Aimone et al.,
2011; Ming and Song, 2011; Miller and Hen, 2015), and that
altered adult neurogenesis and hyppocampal lesions have been
repeatedly related to neuropsychiatric conditions (Parent and
Murphy, 2008; Gonçalves et al., 2016; Inta et al., 2016; Kang et al.,
2016; Yun et al., 2016; Kohman and Rhodes, 2017) and language
disturbances (Sass et al., 1992; MacKay et al., 1998; Covington
and Duff, 2016; Piai et al., 2016).
In this context, we hypothesized that an infection-induced
maternal immune response may cross-react with DLX proteins,
thus possibly causing a first subclinical immune-mediated
damage of the developing nervous system. Later, successive
encounters in adulthood with pathogens able to induce cross-
reactions with DLX proteins might further damage regions of
the adult brain (the subventricular zone and dentate gyrus),
where DLX proteins may be expressed (Lim and Alvarez-Buylla,
2016) thus triggering the onset of neuropsychiatric clinical
manifestations.
Focusing on infections as a trigger of DLX alterations and
seeking for a possible mechanism, we proceeded along three
steps. Firstly, we investigated whether or not infectious pathogens
have the molecular basis to react with human DLX proteins—
that is, we searched for shared peptides that might lead to cross-
reactions. Secondly, we analyzed the immunological potential of
the viral vs. DLX peptide overlap. Thirdly, we collected data on
the expression level of DLX proteins in the fetal and adult human
brain.
METHODS
The primary amino acid (aa) sequences of human DXL1
(Uniprot: P56177, 256 aa), DLX2 (Uniprot: Q07687, 328 aa),
DLX5 (Uniprot: P56178, 289 aa), and DLX6 (Uniprot: P56179;
175 aa) were dissected into pentapeptides offset by one aa
residue: MTMTT, TMTTM,MTTMP, and so forth. Then, each of
the resulting pentapeptides was analyzed for matches to a sample
library of 25 viral proteomes using the Protein Information
Resource (PIR) match program (https://research.bioinformatics.
udel.edu/peptidematch/batchpeptidematch.jsp) (Chen et al.,
2013), as previously described (Kanduc et al., 2008; Lucchese
et al., 2014; Lucchese, 2016, 2017). Neuronal Regeneration-
Related Protein (NREP, Uniprot: Q16612, 68 aa) was used as a
control neural protein. Glutamate decarboxylases 1 (Uniprot:
Q99259; GAD-67; 594 aa) and 2 (Uniprot: Q05329; GAD-65; 585
aa) were additionally investigated as DLX-related proteins.
The virus library consisted of 25 proteomes derived from
the viruses listed as follows (with Abbreviation, NCBI Tax
ID, number of proteins, and aa length in parentheses): Borna
disease virus (BDV; 928296; 6 proteins; 3014 aa); Epstein-Barr
virus (EBV; 82830; 56 proteins; 30727 aa); Hendra virus (HeV;
928303; 9 proteins; 6956 aa); Hepatitis B virus genotype C
subtype ayr (HBV-C; 928302; 5 proteins; 1792 aa); Hepatitis
C virus genotype 1a (HCVH; 11108; 11 proteins; 3011 aa);
Human cytomegalovirus (HCMV; 295027; 168 proteins; 63460
aa); Human herpesvirus 1 (HHV1; 10299; 73 proteins; 38368
aa); Human herpesvirus 2 (HHV2; 10315; 72 proteins; 38122
aa); Human herpesvirus 6A (HHV6A; 10370; 101 proteins; 43629
aa); Human herpesvirus 6B (HHV6B; 36351; 98 proteins; 43692
aa); Human immunodeficiency virus type 1 group M subtype
A (HIV-1; 11697; 9 proteins; 3585 aa); Human parvovirus B19
(HPV-B19; 648237; 5 proteins; 1701 aa); Influenza A virus,
H5N5 (IVA, H5N5; 93838; 12 proteins; 4809 aa); Influenza
A virus, H1N1 (IVA, H1N1; 211044; 12 proteins; 4788 aa);
Influenza A virus, H7N7 (IVA, H7N7; 384493; 12 proteins;
4802 aa); Influenza B virus (FLUBV; 518987; 11 proteins;
4718 aa); Influenza C virus (FLUCV; 11553; 8 proteins;
4259 aa); Measles virus (MeV; 645098; 8 proteins; 5202 aa);
Rotavirus A (RV-A; 450149; 12 proteins; 5897 aa); Rotavirus
C (RV-C; 31567; 11 proteins; 5608 aa); Rotavirus X (RV
ADRV-N; 335103; 11 proteins; 5679 aa); Rubella virus (RUBV;
11045; 5 proteins; 3179 aa); Vaccinia virus (VACV; 10254; 217
proteins; 56795 aa); Varicella-zoster virus (HHV-3; 10338; 69
proteins; 35782 aa); and Zika virus (ZIKV; 64320; 13 proteins;
3419 aa).
The peptide sharing was investigated for immunologic
potential using the Immune Epitope Database (IEDB; www.
iedb.org) resource (Vita et al., 2015). Epitopes that have been
experimentally validated as immunopositive in the human host
were considered.
Laser microdissection microarray data on DLXs and NREP
transcript expression in fetal and adult human brain were
obtained from the online database of the Allen Institute for Brain
Science (http://www.brainspan.org/; http://human.brain-map.
org/) (Lein et al., 2007; Miller et al., 2014). Data on DLX and
NREP protein expression in adult human brain were retrieved
from https://www.proteinatlas.org/humanproteome (Uhlén
et al., 2015; Thul et al., 2017).
RESULTS AND DISCUSSION
A sample library formed by 25 virus proteomes was analyzed
for pentapeptide sharing with DLX proteins. Pentapeptides
were used as probes, for five aa residues represent a minimal
immune-biological determinant in humoral and cellular immune
recognition (Kanduc, 2012, 2013 and further refs. therein). NREP,
a protein involved in neuronal regeneration (Fujitani et al., 2004),
was used as a neural control protein.
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The analyzed viral set consisted of pathogens that have been
reported in studies on language disorders and other cognitive
dysfunctions, bipolar disorders, and schizophrenia (Yolken and
Torrey, 1995; Coplan et al., 1998; Brown et al., 2004, 2006; Torrey
et al., 2006; Baillargeon et al., 2008; Buka et al., 2008; Mortensen
et al., 2010; Arias et al., 2012; Brown, 2012; Hornig et al., 2012;
Khandaker et al., 2013; Blomström et al., 2015; Canuti et al., 2015;
Lucchese, 2016; Ludlow et al., 2016; Soltani et al., 2016).
Pentapeptide Sharing Between DLX
Proteins and Potential Viral Pathogens
The quantitative and qualitative pentapeptide overlap between
the four human TFDLX proteins and NREP vs. the set of 25 virus
proteomes is shown in Table 1.
At a first glance, the following points become apparent when
considering Table 1:
• the neural proteins, including the neuronal regeneration-
related protein NREP, have pentapeptides in common with all
viral proteomes, excluding Borna disease virus and Influenza
B virus;
• DLX2 is the main target of the peptide sharing by being 49%
the level of DLX2 pentapeptide similarity to the 25 proteomes,
i.e., 159 out of 324 DLX2 pentapeptides are shared with the
viral proteomic ensemble;
• the peptide sharing mostly occurs with herpesviruses in
general, and with HCMV in particular. Instead, the peptide
sharing with HeV, HBV-C, RV-C, and RV ADRV-N is
restricted to a few pentapeptides thus indicating a scarce
contribution of such infectious agents in crossreactivity-
triggered DLX alterations and consequent neurological
manifestations;
• the viral pentapeptide distribution is not stochastic. For
example, Vaccinia virus pentapeptides represent 27% of NREP
peptide sharing (i.e., 3 out of 13 pentapeptides) and 4.4% of the
DLX2 peptide sharing (i.e., 7 out of 159 pentapeptides);
• the extent of the peptide sharing is independent of the virus
protein length. For example, Rubella virus (3,179 aa) and
the eleven times longer HHV3 (35,782 aa) share exactly the
same number of pentapeptides—namely, three—with DLX1
protein;
• quantitatively, the extent of the peptide sharing is
unexpectedly high compared to the mathematical expected
value of the pentapeptide sharing between the five neural
proteins and the 25 viral proteomes. The expected value can be
calculated as follows: given two protein entities (for example,
DLX1, and the set of 25 viral proteomes) and assuming that
all aa occur with the same frequency, the expected probability
for the two entities to share a pentapeptide is expressed by the
formula
mn/N2
where: m is the number of pentapeptides present in the DLX1
protein (i.e., 251); n is the number of pentapeptides present
in the set formed by the 25 viral proteomes (i.e., 418,854),
and N is the number of all possible pentapeptides. Since each
residue can be any of 20 aa, then N is 205 (i.e., 3,200,000).
Developing the equation, the expected pentapeptide sharing
between DLX1 and the 25 viral proteomes is equal to
1,02668314453125e-5 or, practically, zero.
The Immunologic Potential of the Viral vs.
DLX Proteins Peptide Overlap
The pentapeptide matching between viral and neural proteins
illustrated in Table 1 has an experimentally documented
immunologic potential. As a matter of fact, exploration of the
Immune Epitope DataBase (IEDB; www.immuneepitope.org;
Vita et al., 2015) shows that almost all shared pentapeptides are
also part of hundreds of epitopes that have been experimentally
validated as immunopositive in humans. Using the epitope aa
length as a filter, Table 2 is restricted to n-mer sequences with
n < 12.
Comparative DLX Transcript Expression in
Fetal and Adult Human Brain
A comparative analysis of DLX expression in fetal and adult
neurogenic areas of the human brain was conducted using the
online database and resources of the Allen Institute for Brain
Science (Lein et al., 2007; Miller et al., 2014). Figure 1 reports
laser microdissection microarray analyses showing that the
transcript expression of the four TFs ranges frommedium to high
in the fetal transient structures of forebrain (ventricular zone
and ganglionic eminence) (Figure 1A), and reaches the lowest
but still detectable value in the adult neurogenic dentate gyrus
(Figure 1B, subareas CA1, CA2, CA3, and CA4). Notably, only
DLX5 and DLX6 appear to be expressed in basal ganglia of adult
brain, that is, substantia innominata, caudate nucleus, nucleus
accumbens, and putamen (Figure 1B). The control neuronal
regeneration-related protein NREP is widely expressed through
almost all fetal and adult brain areas, except the fetal ventricular
zone and ganglionic eminence (Figure 1A) as well as the dentate
gyrus area in the adult brain (Figure 1B).
DLX Protein Expression in Fetal and Adult
Human Brain
On the whole, Figure 1 theoretically supports the possibility
that the cross-reactivity scenario outlined in Tables 1, 2 may
occur in neurogenic areas in the fetal life of an individual
and then possibly recur in adulthood. However, from an
immunological point of view, a condition that is necessary for the
cross-reactivity hypothesis to be biologically plausible depends
on sufficient DLX antigen expression in the brain. In other
words, data of Figure 1 need to be substantiated in a protein
context.
Actually, few data are available on DLX protein expression
in humans. Rakic and Zecevic (2003) studied DLX expression
in the late human embryonic period (Carnegie stages 19–
20) and showed that DLX2 protein was widely distributed
through the ganglionic eminence and dorsal telencephalon.
Moreover, immunocytochemistry based on a pan-DLX antibody
that recognizes DLX 1, 2, 5, and 6 revealed that, in the developing
brain, 11 gestational week, DLX protein expression is present
in all cortical layers, including layer I and the subpial granular
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layer (SGL). Almost all small GABAergic cells of the SGL were
labeled with the pan-DLX antibody. Successively, using the same
pan-DLX antibody, Jakovcevski et al. (2011) showed labeling of
the neocortical VZ/SVZ and of the cortical plate in human fetal
forebrains during the first half of gestation.
Such experimental results obtained in human fetal developing
brain are flanked by data collected from the Human Protein
Atlas (https://www.proteinatlas.org/on DLX1 and DLX5 protein
expression in the adult human brain. The data are shown in
Figure 2. It can be seen that human DLX1 and DLX5 have a
protein expression from low to medium level, that is, sufficient to
sustain immune cross-reactions. No protein expression data were
available for DLX2 and DLX6 proteins. The control NREP had
the highest levels of protein expression (from medium to high in
the cerebral cortex and the cerebellum).
In essence, we found a vast and unexpected peptide sharing
between DLX proteins and numerous infectious agents that
constellate human life, from prenatal time to adulthood. The
peptide platform defined in Table 1 has also a high immunologic
potential, as documented in Table 2, so that, on the whole, data
from Tables 1, 2 show the existence of a wide immunologic
peptide platform common to viral and human DLX proteins.
Moreover, data on protein expression from literature (Rakic
and Zecevic, 2003; Jakovcevski et al., 2011) and Figure 2 (www.
proteinatlas.org; Uhlén et al., 2015; Thul et al., 2017), although
few in numbers and fragmentary, support the possibility that
mild, subclinical anti-DLX autoimmune damage in the fetal brain
structures evoked by maternal viral infections (and consequent
maternal immune activation) may be followed in the adult brain
by additional damage after a second encounter with the same
pathogen or novel infection with a different agent sharing the
same epitopic sequences.
In this context, different immunological pathogenic
mechanisms might be theoretically account for the neuronal
damage according to the type of immune response, i.e., humoral
vs. cell-mediated, and the timing of infection-induce maternal
immune activation in relationship to the expression patterns of
DLX proteins in the fetus (see Figure 1). The main hypothesis
that we considered here relates to maternal infection and
consequent immune activation that may also be antecedent to
pregnancy and are followed by antibody–mediated neuronal
damage in the fetus due to cross-reactions with DLX proteins.
In such a scenario, the passage in the fetus of maternal memory
B cells (Vernochet et al., 2005, 2007) against epitopes shared
between the pathogen(s) and DLX proteins might induce an
immune response targeting the developing nervous systems,
where DLX proteins are expressed early (see Figure 1). Cellular
damage from (auto)antibodies targeting intracellular antigens,
like the DLX family of TFs may be, not only plays a pathogenic
role in a variety of autoimmune diseases (Racanelli et al., 2011)
but even represents a promising therapeutic strategy for cancer
treatment (Weisbart et al., 2012; Wang et al., 2015; Chan et al.,
2016). The notion that autoantibodies can penetrate living
cells is not new. Alarcon-Segovia et al. (1978) showed that
antibodies can penetrate living cells. In more recent years, more
evidence has accumulated showing autoantibody penetration
into different types cell, including neurons, and proposing
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TABLE 2 | Epitopes experimentally validated as immunopositive in the human host and containing pentapeptides common to the analyzed neural and viral proteins.
IEDB IDa Epitope sequenceb IEDB IDa Epitope sequenceb IEDB IDa Epitope sequenceb
38471 lpfEKSTVm 452745 appPALPPk 504154 aAELAAaaal
52131 vvpiASLTPy 453106 dLQATAldlew 504458 anGGGGGg
55320 rprGEVRFl 453171 eaLAALQaan 505711 grAGGGGPg
59401 sLPPPGtrv 454071 GGGGSrselvi 507555 PPVPPGtpmip
59519 SLTPLlfnydva 455984 LASGTpsani 507767 rkKAYADfy
78372 ELAASaivg 456139 lgtASLAQv 508461 sshsNSSSSsl
103335 lALEGSlqk 456387 llspGGPGStl 509354 daAASLTv
120627 iLPPPGy 456448 lnkSRPLGae 509896 LPPPGlti
124186 gftpGGGGS 458627 ryLAALQll 512096 ASSYLsltpeqw
131762 yaASSYL 459338 spdlgHSTQI 515359 esvaAALSPlg
146495 phvpPPVPP 459581 spSFSRPast 517427 GRLPVPkevnr
157857 rlGGAALprv 459696 sspEDPGAev 520364 krleKLLKQal
159292 plALEGSlqk 463283 aPALPPpaf 533287 phlgPPVPP
162373 gqrkSASSF 465679 glffPGSGGvit 542463 gqkPSSSDtf
162661 kiKEVTEev 466693 ipAGSSGSkflal 543080 iwlpFPVLL
179892 rpvPVSTAr 467021 iYIPSYfdf 544315 NSSSSstdsetlry
179919 vrpvPVSTA 467100 iyqGSSGSyf 544506 PVPPGgsrsnf
202757 asttRAELAy 468008 lPALPPslv 545645 tfSVSSHlf
218741 rvtYPAKAk 468164 lpPPPGSpl 551934 GGGGGggrfs
219023 sehGGGAGnnw 468966 nfGGGGGnf 552106 glGSGGSir
219569 stAHPPTgk 469915 rfiapAASLGf 555776 rsGGGGGggl
219711 SVSSHlfthk 470483 slAGSSGpga 561784 tPAGGGfpr
222414 gedaGGGAGrel 470910 spiiGSPPV 563865 htfNSSSSqy
222458 gEGSALeksl 471048 SPPVPgpsaal 570436 apgpaPPVSA
226892 rrlgPVPPGl 471225 SPVSGgvnl 570600 aPSSAAwvqtl
236284 qrkKAYADf 473075 vyAALQRqll 574225 kPALPPasl
239392 allAGGGGPpak 473232 vymLAASLl 574257 kplsSLTPLia
239680 fSASLAphfnsl 473386 vYYPELfvw 574258 kplsSLTPLiaa
241439 rRLPVPrak 474572 AALQRqll 574430 KRSKIksfvk
423867 afSLTPLey 474610 AASSIqrvl 576991 rqavGGAGPp
424337 ffdPAGGGd 475051 aeilGSGAGi 577112 RRFQKnihr
424618 fNSSSSfry 475122 AELAAhepai 581699 ahalnDSLVAl
425055 gsnfGGGGSy 475184 aeNAGSYsl 584847 kkkagPGSLQk
425181 gyGGGGPgy 478174 fpQPEKEsf 587586 PTSASrksl
425535 ifsgAASLGy 478359 geaGGGAGl 587901 rahPALPPl
426679 PAGGGdpily 478463 gelPAGGGl 588460 riAKAYAan
426734 qfGSALAhfy 478519 getGGGGGSal 585095 kplsSLTPL
427287 sifsgAASLGy 478693 gLNSPVligk 590425 tRLPKGavlyk
427412 snfGGGGSy 480790 KLLKQvdfl 589031 RRFQKtknll
427447 sSASLAasy 483709 qypGSALAl 590702 vhGRLPVhgv
427741 tffdPAGGGd 483949 reqVRFNGf 597556 KAYADfyrny
427753 tflnPALPPgysy 484016 rgilkrNSSSSstds 599267 lSSELRsvlvm
428949 YYPELafqf 484222 rlGGGGSpr 605152 hrLAALQhrl
435141 GRLPVahpgt 484341 RLPKGavlyk 605536 qrkKAYADfy
436575 ASLGLkfnk 484374 rlrlGGAAL 605589 rqiAKAYAr
437241 feqLAALQi 484531 rprGGGAGgssv 606593 aPALPPaaall
437831 gtPAGGGfpr 485822 sEVTEPdhpvl 608552 GRLPVvvplh
442711 aptkPQSPA 485924 shhPPVSAf 611431 RRFQKtknl
443226 dPPPGShvi 486263 sPAGGGaeal 614993 eaGSSRSqei
444635 GTSSSaasslk 486272 spaNSSSSl 615286 ehlGTSSSl
(Continued)
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TABLE 2 | Continued
IEDB IDa Epitope sequenceb IEDB IDa Epitope sequenceb IEDB IDa Epitope sequenceb
444517 GRLPVglsl 486452 sptSSASSF 616774 ghfpQPEKEsf
445920 kRLPVPesitgf 486557 SSASSsvtdly 617119 grwsGGSGA
446133 lefEGGEVsl 486749 stiNSSSSvvhk 617562 HHHHHpvspa
446393 lpRLPVPav 487343 teqdPGSASa 619990 krleKLLKQ
464008 dASLTPwtv 488260 vlrGGGGSpr 619991 krleKLLKQa
446422 lpswgRAELAl 488347 vpsGSSGSl 628491 YPAKAkgtf
447091 qHLQATgvsl 488735 yaASSYLsl 629394 alYYPELyilk
448056 rvPPVPPnv 491894 grSLTPLsl 632427 iGSLQHiksr
449644 vlfgKALNPk 492854 kRLPVPesi 633424 kSLTPLqw
451656 aeADSEKarll 495589 tRLPKGavly 645286 ispPPVSAv
452446 alSASLArv 496005 wrlrlGGAAL 647258 lqnLENSAf
452673 aPGSASgpl 496112 yrgvLNSPV 647281 lqRLPVPal
aEpitopes listed according to the IEDB ID number. References at www.immuneepitope.org/.
bPeptide sequences common to neural proteins and potential viral pathogens in capital.
FIGURE 1 | Comparative analyses of DLX1, DLX2, DLX5, and DLX6 transcript expression in fetal (15 post-conception weeks, pcw; A) and adult (24 years; B) human
brain. The symbol H localizes neurogenic areas of developing and adult brain. The figure assembles images and data from the Allen Institute. Further details on
donors, DNA probes, complete transcriptome profiles, and methodology can be found at http://www.brainspan.org/ and http://human.brain-map.org/ (Lein et al.,
2007; Miller et al., 2014).
mechanisms that may explain a pathogenic role of internalized
immunoglobulins in autoimmune diseases (Koren et al., 1995;
Koscec et al., 1997; Portales-Pérez et al., 1998; Ruíz-Argüelles
et al., 1998, 2003, 2007; Ronda et al., 2002; Proulx et al., 2009).
Moreover, a nuclear-penetrating lupus anti-DNA autoantibody,
3E10, has been found to inhibit DNA repair and selectively
kill certain cancer cells that are highly vulnerable to DNA
damage (Weisbart et al., 2012), and, of special importance,
nuclear-penetrating anti-dsDNA autoantibodies could possibly
function as a pathogenic autoimmune factor for lupus nephritis
(Im et al., 2015). Bearing even more relevance to the present
discussion, antibodies targeting intracellular antigens, like for
instance the glutamic acid decarboxylase, appear to be also
involved specifically in neuropsychiatric disorders, like CNS
lupus (Karimifar et al., 2013), limbic encephalitis (Matà et al.,
2008), schizophrenia (Najjar et al., 2012), and autism (Rout et al.,
2012). Indeed, the glutamic acid decarboxylase isoforms (Gad1
and Gad2), which regulate GABA synthesis from the excitatory
neurotransmitter glutamate and whose expression is activated
by DLX1 and/or DLX2 (Stühmer et al., 2002a,b; Le et al., 2017),
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FIGURE 2 | DLX1, DLX5, and NREP protein expression in adult human brain. Estimate of the protein expression are: not detected (n), low (l), medium (m), or high (h).
Data for DLX2 and DLX6 proteins were not available or pending. The figure assembles images and data from www.proteinatlas.org (Uhlén et al., 2015; Thul et al.,
2017).
share numerous pentapeptides with the 25 viral proteomes
(see Supplementary Table 1). Hence, a scenario emerges where
immune responses following infections might cause a cascade of
multiple crossreactions at multiple levels (i.e., DLX, GAD) of the
intracellular mechanisms regulating the function of GABAergic
neurons and altering the excitation and inhibition ratio, which
is necessary for normal neural circuit function and whose
imbalance contributes to neurodevelopmental diseases (Kang,
2017; Maffei et al., 2017; Ye and Kaszuba, 2017; Catavero et al.,
2018; Garret et al., 2018).
On the other hand, a cell-mediated mechanism could also
theoretically be implied in the cross-reactive immune-mediated
subclinical damage of the fetal nervous systems, since memory
T-cell trafficking between mother and fetus is also a well-
known phenomenon (Jeanty et al., 2014). Nevertheless, the
hypothesis of a cell-mediated response would need to take into
account the late MHC expression in the fetal CNS (Elmer
and McAllister, 2012; Zhang et al., 2013, 2015; McAllister,
2014) that might not sit well with the very early pattern of
expression of the DLX-proteins in the fetus seen in Figure 1.
However a later cell-mediated damage, and even the possible
occurrence of both humoral and cell-mediated responses at
different stages of the fetal neural development, can still be
hypothesized.
Based on data from Figure 2 and, consequently, confining
our discussion to DLX1 and DLX5 proteins, we observe
that infection-induced immune cross-reactions might have
functional, spatial, and temporal implications:
• Functionally, infection-induced immune cross-reactions
would affect two TFs that, according to numerous studies, are
implicated in crucial functions and fundamental processes
during neurodevelopment and adult neurogenesis, and are
potentially relevant to language competence and other higher
cognitive functions (see Box 1);
• Spatially, infection-induced immune cross-reactions would
damage brain structures where adult neurogenesis occurs and
that are involved in the neural circuitry of language and
memory, and in cognitive and emotional functions (Ming
and Song, 2011). Altered human neurogenesis is linked
to neuropsychiatric conditions and to impaired cognition
(Aimone et al., 2014). Also, alterations of the SVZ and
hippocampus have been specifically related to some of the
pathogenic and symptomatic aspects of schizophrenia (Reif
et al., 2006, 2007; Duan et al., 2007; Toro and Deakin, 2007;
Christian et al., 2010; Aimone et al., 2014; Allen et al., 2016;
Kang et al., 2016; Yun et al., 2016; Iannitelli et al., 2017;
Terrillion et al., 2017).
• Temporally, infection-induced immune cross-reactions
suggest a two-hit model that, depending on the DLX protein
expression profiles, comprehends targets allocated in two
time-windows in the life of an individual with a subclinical
damage in fetal life and clinical onset in adulthood.
CONCLUSION
In synthesis, the present study confirms previous reports
(Kanduc et al., 2008; Lucchese et al., 2014; Lucchese, 2017)
and supports the hypothesis that an autoimmune connection
exists at the molecular level among infections, autoimmune
reactions and neuropsychiatric disorders. Such a connection
implies a vast viral vs. neural proteins peptide overlap and
operates through cross-reactivity mechanisms. To test this
hypothesis in vivo, the possibility of obtaining animal models
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BOX 1 | DLX1 and DLX5 functions and relevance to neuropsychiatric disturbances.
DLX1:
• regulates the development of the ventral forebrain, craniofacial patterning, and the early diencephalic subdivision (Eisenstat et al., 1999; Merlo et al., 2000; Letinic
and Rakic, 2001; Letinic et al., 2002).
• regulates neurite maturation and migration (Cobos et al., 2007) and interneuron differentiation (Wonders and Anderson, 2005).
• regulates the fate switch between cortical and striatal interneurons: cells that ordinarily would become cortical interneurons transform toward a subtype of
GABAergic striatal interneurons, thus reducing glutamatergic input to the hippocampus (McKinsey et al., 2013).
• its loss leads to subtype-specific loss of inhibitory interneurons with a reduction in inhibitory currents and generalized seizures in mice (Cobos et al., 2005; Jones
et al., 2011).
• contributes to promote cortical interneuron migration from the basal forebrain by direct repression of the semaphorin receptor neuropilin-2 (Le et al., 2017).
• when altered, might be related to Mowat-Wilson syndrome (McKinsey et al., 2013).
• is downregulated or altered in autism spectrum disorders (ASD; Liu et al., 2009; Voineagu et al., 2011; Benítez-Burraco et al., 2016).
• has low thalamic expression in psychosis (Kromkamp et al., 2003).
• has been proposed as a language-associated protein (Boeckx and Benítez-Burraco, 2014; Benítez-Burraco et al., 2016; Murphy and Benítez-Burraco, 2016,
2017) and relates to language deficits in schizophrenia (Murphy and Benítez-Burraco, 2016).
DLX5:
• promotes neuronal differentiation in SVZ (Shu et al., 2010).
• its loss leads to defective neuronogenesis (Perera et al., 2004).
• contributes to convert fibroblasts into induced GABAergic interneurons (Colasante et al., 2015).
• regulates development of peripheral and central components of the olfactory system (Long et al., 2003).
• is a candidate genes for autism (Nakashima et al., 2010).
• is involved in Rett syndrome (Itaba-Matsumoto et al., 2007; Itoh et al., 2007).
• participates to the regulation of the expression of the glutamic acid decarboxylases (Stühmer et al., 2002a).
• its loss preferentially reduces the number of mature parvalbumin- interneurons (Wang et al., 2010).
of neuropsychiatric disorders by immunizing pregnant animals
with DLX proteins could be examined. Moreover, analyses of sera
from human patients with neuropsychiatric diseases, for example
schizophrenia, are warranted to measure immunoreactivity
against the peptides shared between viruses and DLX proteins.
Possibly, the results of these joint basic and clinical in vivo
approaches might also help design new therapeutic approaches
in neuropsychiatry.
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